The accumulation of aberrations in gene expression accurately recapitulates the clinical progression from low- to high-grade gliomas in patients, whereby loss of p53 function in low-grade astrocytomas precedes further genetic and gene expression changes that ultimately lead to progression and development of high-grade gliomas [40]. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).